Asia Pacific Academy of Science Pte. Ltd. (APACSCI) specializes in international journal publishing. APACSCI adopts the open access publishing model and provides an important communication bridge for academic groups whose interest fields include engineering, technology, medicine, computer, mathematics, agriculture and forestry, and environment.
Effects of RNA interference silencing SOX9 on proliferation, apoptosis and tumorigenicity of renal cell carcinoma 786-O cells in vitro
Vol 4, Issue 2, 2023
VIEWS - 1896 (Abstract)
Download PDF
Abstract
Objective: To investigate the effect of RNA interference silencing of SOX9 (sex determining region Y-box 9) on the proliferation, apoptosis and tumorigenicity of renal cell carcinoma 786-O cells in vitro. Methods SOX9-specific small interfering RNA (small interfering RNA) , siRNA) sequence was the experimental silencing group, and the non-specific siRNA sequence was the control group and were transfected into 786-O cells respectively. The proliferation of 786-O cells was detected by CCK-8 assay and plate clone formation assay, and Hoechst 33342 cell staining was used to detect the proliferation of 786-O cells. Apoptosis of 786-O cells. The effect of RNA interference silencing SOX9 on tumorigenic ability of animals was detected by tumorigenic assay in nude mice. The expression of proliferating antigen Ki-67 protein was detected by immunohistochemistry. Compared with the control group, the OD value of the SOX9 silencing group was significantly lower, and the number of cell colonies was significantly lower than that of the control group, and the difference was statistically significant (P<0.05). Statistical significance (P<0.05). The results of animal tumorigenesis experiments showed that the volume and weight of the tumor in the SOX9 silencing group were significantly lower than those in the control group, and the difference was statistically significant (P<0.05). Immunohistochemical staining showed that the siRNA silencing group The proportion of Ki-67 positive cells was significantly lower than that in the control group, and the difference was statistically significant (P<0.05). Conclusion RNA interference silencing of SOX9 can significantly inhibit the proliferation of renal cell carcinoma 786-O cells, promote their apoptosis, and inhibit renal cell carcinoma 786-O cells. Cancer cell proliferation in nude mice.
Keywords
References
1. Siegel RL,Miller KD,Jemal A. Cancer statistics[J]. CA Cancer J Clin,2017,67(1):7⁃30.
2. Zhao L,Koopman P. SRY protein function in sex de⁃ termination:thinking outside the box[J]. Chromo⁃ some Res,2012,20(1):153⁃162.
3. Qian Y,Xia S,Feng Z. SOX9 mediated transcriptional activation of FOXK2 is critical for colorectal cancer cells proliferation[J]. Biochem Biophys Res Com⁃ mun,2017,483(1):475⁃481.
4. Capaccione KM,Hong X,Morgan KM,et al. SOX9 mediates Notch1 ⁃ induced mesenchymal features in lung adenocarcinoma[J]. Oncotarget,2014,5(11): 3636⁃3650.
5. Camaj P,Jäckel C,Krebs S,et al. Hypoxia⁃indepen⁃ dent gene expression mediated by SOX9 promotes ag⁃ gressive pancreatic tumor biology [J]. Mol Cancer Res,2014,12(3):421⁃432.
6. Crowley LC,Marfell BJ,Waterhouse NJ. Analyzing cell death by nuclear staining with Hoechst 33342[J]. Cold Spring Harb Protoc,2016,2016(9):pdb. prot087205.
7. Fu L,Shi YB. The Sox transcriptional factors:Func⁃ tions during intestinal development in vertebrates[J]. Semin Cell Dev Biol,2017,63:58⁃67.
8. Yin C. Molecular mechanisms of Sox transcription fac⁃ tors during the development of liver,bile duct,and pancreas[J]. Semin Cell Dev Biol,2017,63:68⁃78.
9. Wang S,Tie J,Wang R,et al. SOX2,a predictor of survival in gastric cancer,inhibits cell proliferation and metastasis by regulating PTEN[J]. Cancer Lett, 2015,358(2):210⁃219.
10. Guo X,Yang M,Gu H,et al. Decreased expression of SOX6 confers a poor prognosis in hepatocellular Carcinoma[J]. Cancer Epidemiol,2013,37(5):732 ⁃736.
11. Oh KY,Hong KO,Huh YS,et al. Decreased expres⁃ sion of SOX7 induces cell proliferation and invasion and correlates with poor prognosis in oral squamous cell carcinoma[J]. J Oral Pathol Med,2017,46(9): 752⁃758.
12. Riemenschnitter C,Teleki I,Tischler V,et al. Stabili⁃ ty and prognostic value of Slug,SOX9 and Sox10 ex⁃ pression in breast cancers treated with neoadjuvant che⁃ motherapy[J]. Springerplus,2013,2:695.
13. Liu H,Liu Z,Jiang B,et al. SOX9 overexpression promotes glioma metastasis via Wnt/ β⁃ Catenin Signal⁃ ing[J]. Cell Biochem Biophys,2015,73(1):205⁃ 212.
14. Wang HY,Lian P,Zheng PS. SOX9,a potential tu⁃ mor suppressor in cervical cancer, transactivates p21WAF1/CIP1 and suppresses cervical tumor growth [J]. Oncotarget,2015,6(24):20711⁃20722.
15. Burdelski C,Bujupi E,Tsourlakis MC,et al. Loss of SOX9 expression is associated with PSA recurrence in ERG⁃positive and PTEN deleted prostate cancers[J]. PLoS One,2015,10(6):e0128525.
16. Wan YP,Xi M,He HC,et al. Expression and clini⁃ cal significance of SOX9 in renal cell carcinoma,blad⁃ der cancer and penile cancer [J]. Oncol Res Treat, 2017,40(1⁃2):15⁃20.
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 Guangmin Chu, Jianbo Zhang, Miaomiao Sun
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
.png)
Prof. Wei-Yen Hsu
National Chung Cheng University, Taiwan
